Sarepta Therapeutics, Inc. company logo
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. (SRPT) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$1.10B$674.58M+157.45%

Summary

Current Value
As of today, SRPT annual cash & cash equivalents is $1.10B, up +157.45% on
Historical Performance
SRPT annual cash & cash equivalents is down -47.87% over the past 3 years, and up +32.08% over the past 5 years
All-Time High Comparison
SRPT annual cash & cash equivalents is currently -47.87% below its historical high of $2.12B set on
3-Year Low Comparison
SRPT annual cash & cash equivalents is +157.45% above its 3-year low of $428.43M reached on
Sector Comparison
SRPT annual cash & cash equivalents is higher than 93.98% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

SRPT Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$1.10B+157.4%-47.9%+32.1%+2184.8%
Quarterly Cash & Cash Equivalents$850.99M-29.0%-58.9%-53.1%
Price$21.46-81.9%-83.1%-76.1%+43.6%
Annual Current Assets$3.07B+19.2%+18.0%+109.2%+5890.0%
Annual Total Liabilities$2.44B+1.3%+9.7%+142.4%+6591.3%
Annual Working Capital$2.34B+21.6%+8.8%+94.5%+10000.0%
Annual Net Income$235.24M+143.9%+156.2%+132.9%+1035.0%

Cash and Cash Equivalents Highs

SRPT Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$1.10Bat high
5Y$2.12B-47.9%
All$2.12B-47.9%

Cash and Cash Equivalents Lows

SRPT Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$428.43M+157.4%
5Y$428.43M+157.4%
All$3.00M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$1.10B+157.5%
$428.43M-55.7%
$966.78M-54.3%
$2.12B+40.8%
$1.50B+79.9%
$835.08M+125.2%
$370.83M-38.2%
$599.69M+389.9%
$122.42M+52.4%
$80.30M+9.2%
$73.55M-71.4%
$256.97M+36.9%
$187.66M+370.3%
$39.90M+18.8%
$33.59M-30.4%
YearValueChange
$48.28M+331.3%
$11.19M-54.9%
$24.80M+23.0%
$20.16M-41.7%
$34.60M+107.7%
$16.65M+33.0%
$12.52M+20.6%
$10.39M-6.2%
$11.07M-57.3%
$25.90M+197.7%
$8.70M+2.4%
$8.50M-51.7%
$17.60M+486.7%
$3.00M-

FAQ

  • What is the current annual cash & cash equivalents of SRPT?

    As of today, SRPT annual cash & cash equivalents is $1.10B

  • What is 1-year change in SRPT annual cash & cash equivalents?

    SRPT annual cash & cash equivalents is up +157.45% year-over-year

  • What is 3-year change in SRPT annual cash & cash equivalents?

    SRPT annual cash & cash equivalents is down -47.87% over the past 3 years

  • How far is SRPT annual cash & cash equivalents from its all-time high?

    SRPT annual cash & cash equivalents is currently -47.87% below its historical high of $2.12B set on December 31, 2021

  • How does SRPT annual cash & cash equivalents rank versus sector peers?

    SRPT annual cash & cash equivalents is higher than 93.98% of companies in Healthcare sector

  • When is SRPT next annual earnings release?

    The next annual earnings release for SRPT is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. SRPT Official Website www.sarepta.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/873303/000119312525262591/0001193125-25-262591-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/873303/000095017025029973/0000950170-25-029973-index.htm
  4. SRPT Profile on Yahoo Finance finance.yahoo.com/quote/SRPT
  5. SRPT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/srpt